e-learning
resources
Munich 2006
Sunday 03.09.2006
Highlights of epidemiology of COPD and lung function
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Early life origins of adult lung function
C. Svanes, J. Sunyer, E. Plana, J. M. Antó, on behalf of the Early Life Working Group at ECRHS (Bergen, Norway; Barcelona, Spain)
Source:
Annual Congress 2006 - Highlights of epidemiology of COPD and lung function
Session:
Highlights of epidemiology of COPD and lung function
Session type:
Oral Presentation
Number:
1709
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Svanes, J. Sunyer, E. Plana, J. M. Antó, on behalf of the Early Life Working Group at ECRHS (Bergen, Norway; Barcelona, Spain). Early life origins of adult lung function. Eur Respir J 2006; 28: Suppl. 50, 1709
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Lung function measurement in respiratory diseases: mechanisms
Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease
Year: 2006
Prediction of all cause mortality in a population sample is improved by using FEV
1
quotient
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics
Source: Eur Respir J 2003; 21: 95-10
Year: 2003
Pulmonary issues in adolescence and adulthood
Source: Annual Congress 2005 - Cystic fibrosis: no longer just kids‘ stuff
Year: 2005
Why should we perform lung function tests?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007
Lung function decline, chronic bronchitis and occupational exposures during the follow-up of the ECRHS
Source: Annual Congress 2005 - Better understanding of lung function decline and COPD
Year: 2005
Application and interpretation in RCT's
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006
Evidence for the onset of COPD in childhood, and the role of genetics
Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence
Year: 2005
FEV6 or FVC to detect airway obstruction in the community setting?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007
Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids
Source: Annual Congress 2006 - New features of paediatric asthma
Year: 2006
Does rapid decline predict poor prognosis?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002
Basic principles of lung mechanics
Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease
Year: 2006
Nutritional status from birth to adulthood and lung function in Chilean young adults
Source: Annual Congress 2005 - Better understanding of lung function decline and COPD
Year: 2005
Annual decline in forced expiratory volume and airways inflammatory cells, mediators in general population based sample.
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017
The effect of nebulised MgSO4 on lung function in stable severe asthma patients with persistent airflow limitation
Source: Annual Congress 2007 - New drugs for asthma
Year: 2007
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes
Source: Eur Respir J 2007; 30: 616-622
Year: 2007
FEF
25-75%
should not yet be used to define a bronchodilator response in individuals
Source: Annual Congress 2005 - Spirometry - now and in the future
Year: 2005
Home telemonitoring (forced expiratory volume in 1 s) in children with severe asthma does not reduce exacerbations
Source: Eur Respir J 2012; 39: 290-296
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept